Rep. Gilbert Ray Cisneros, Jr. Buys The Cooper Companies, Inc. (NASDAQ:COO) Stock

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of The Cooper Companies, Inc. (NASDAQ:COO). In a filing disclosed on January 12th, the Representative disclosed that they had bought between $1,001 and $15,000 in Cooper Companies stock on December 10th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Xiaomi (OTCMKTS:XIACF) on 12/30/2025.
• Sold $1,001 – $15,000 in shares of Schneider Electric S.E. (OTCMKTS:SBGSF) on 12/30/2025.
• Sold $1,001 – $15,000 in shares of Hermès International Société en commandite par actions (OTCMKTS:HESAF) on 12/30/2025.
• Purchased $50,001 – $100,000 in shares of Campbell’s (NASDAQ:CPB) on 12/30/2025.
• Sold $1,001 – $15,000 in shares of Tencent (OTC:TCTZF) on 12/30/2025.
• Sold $1,001 – $15,000 in shares of Mitsubishi Heavy Industries (OTCMKTS:MHVYF) on 12/26/2025.
• Sold $1,001 – $15,000 in shares of Bloom Energy (NYSE:BE) on 12/24/2025.
• Sold $1,001 – $15,000 in shares of Arista Networks (NYSE:ANET) on 12/24/2025.
• Sold $1,001 – $15,000 in shares of Coinbase Global (NASDAQ:COIN) on 12/24/2025.
• Sold $1,001 – $15,000 in shares of Chevron (NYSE:CVX) on 12/24/2025.

Cooper Companies Stock Performance

Shares of NASDAQ COO traded up $0.62 during mid-day trading on Thursday, hitting $82.31. The company had a trading volume of 2,418,262 shares, compared to its average volume of 2,466,694. The stock has a market cap of $16.13 billion, a price-to-earnings ratio of 43.78, a PEG ratio of 2.33 and a beta of 1.03. The firm’s 50 day simple moving average is $78.71 and its two-hundred day simple moving average is $73.58. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.89 and a quick ratio of 1.13. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $100.24.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, December 4th. The medical device company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.11 by $0.04. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The firm had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.06 billion. During the same quarter in the prior year, the firm earned $1.04 EPS. Cooper Companies’s quarterly revenue was up 4.6% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. As a group, equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies announced that its Board of Directors has authorized a share repurchase plan on Wednesday, September 17th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the medical device company to buy up to 15.4% of its shares through open market purchases. Shares buyback plans are often an indication that the company’s leadership believes its shares are undervalued.

Insider Buying and Selling

In other news, Director Cynthia L. Lucchese bought 1,784 shares of the company’s stock in a transaction that occurred on Monday, December 22nd. The stock was acquired at an average price of $84.06 per share, for a total transaction of $149,963.04. Following the transaction, the director directly owned 9,445 shares of the company’s stock, valued at $793,946.70. This trade represents a 23.29% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Albert G. White III acquired 10,000 shares of the firm’s stock in a transaction on Tuesday, December 16th. The shares were purchased at an average cost of $80.80 per share, for a total transaction of $808,000.00. Following the completion of the purchase, the chief executive officer directly owned 236,151 shares of the company’s stock, valued at approximately $19,081,000.80. The trade was a 4.42% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired 16,014 shares of company stock worth $1,304,416 in the last three months. Company insiders own 1.98% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on COO shares. Robert W. Baird boosted their price target on shares of Cooper Companies from $85.00 to $98.00 and gave the stock an “outperform” rating in a research report on Friday, December 5th. Weiss Ratings raised Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday. Mizuho set a $100.00 price target on Cooper Companies and gave the stock an “outperform” rating in a research note on Friday, December 5th. Barclays reaffirmed an “overweight” rating and issued a $91.00 price target on shares of Cooper Companies in a research report on Monday, December 8th. Finally, Morgan Stanley raised their target price on shares of Cooper Companies from $76.00 to $83.00 and gave the company an “equal weight” rating in a research note on Monday, December 8th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $90.31.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Bell Investment Advisors Inc grew its stake in shares of Cooper Companies by 106.3% in the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock valued at $29,000 after purchasing an additional 219 shares during the period. J.Safra Asset Management Corp boosted its stake in Cooper Companies by 204.8% in the 2nd quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock valued at $36,000 after buying an additional 340 shares in the last quarter. CYBER HORNET ETFs LLC bought a new stake in Cooper Companies in the second quarter valued at $36,000. True Wealth Design LLC raised its stake in Cooper Companies by 484.8% during the fourth quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after acquiring an additional 383 shares in the last quarter. Finally, Board of the Pension Protection Fund bought a new position in shares of Cooper Companies during the fourth quarter valued at $41,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.